| Richelle Florence Torres Santos, PT, DPT | |
|
2669 Scenic Dr, Alamogordo, NM 88310-8700 | |
| (575) 439-6100 | |
| Not Available |
| Full Name | Richelle Florence Torres Santos |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2669 Scenic Dr, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083344386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT4824 (New Mexico) | Primary |
| Provider Name | Otero County Hospital Association |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861450579 PECOS PAC ID: 3173516606 Enrollment ID: O20070212000377 |
News Archive
ImThera Medical, Inc. has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera's Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat Obstructive Sleep Apnea (OSA). Along with the clinical trial approvals, ImThera has received ISO 13485 certification of its quality system as a pre-requisite for the future CE mark application for European commercialization of medical products.
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for omeprazole 20mg/sodium bicarbonate 1100mg, the generic equivalent of Zegerid OTC™, and that it provided prior notice of this filing to Schering-Plough HealthCare Products, Inc. a subsidiary of Merck & Co., Inc., the owner of the brand regulatory approval and the Curators of the University of Missouri, the listed patent owner.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richelle Florence Torres Santos, PT, DPT 2669 Scenic Dr, Alamogordo, NM 88310-8700 Ph: () - | Richelle Florence Torres Santos, PT, DPT 2669 Scenic Dr, Alamogordo, NM 88310-8700 Ph: (575) 439-6100 |
News Archive
ImThera Medical, Inc. has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera's Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat Obstructive Sleep Apnea (OSA). Along with the clinical trial approvals, ImThera has received ISO 13485 certification of its quality system as a pre-requisite for the future CE mark application for European commercialization of medical products.
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for omeprazole 20mg/sodium bicarbonate 1100mg, the generic equivalent of Zegerid OTC™, and that it provided prior notice of this filing to Schering-Plough HealthCare Products, Inc. a subsidiary of Merck & Co., Inc., the owner of the brand regulatory approval and the Curators of the University of Missouri, the listed patent owner.
› Verified 3 days ago
Chris Kotter, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2351 Indian Wells, Alamogordo, NM 88310 Phone: 575-439-1397 | |
Oliver C Nuique, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2351 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-3351 Fax: 575-437-2622 | |
Matthew Anthony Larkin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-446-7532 | |
Alamogordo Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 2351 Indian Wells, Alamogordo, NM 88310 Phone: 575-439-1397 Fax: 575-437-2622 | |
Zachary Carr, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2351 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-3351 Fax: 575-437-2622 | |
Scott Nufer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1011 10th St, A, Alamogordo, NM 88310 Phone: 575-439-9878 Fax: 575-439-9876 | |
Emily Pattillo, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2351 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-3351 |